Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: 2MAR$ who wrote (104501)	1/13/2004 7:16:03 PM
From: stormrider1	Read Replies (1) \| Respond to of 208838

ADLR dumps a/h. Might be a nice volatile one to watch tomorrow. ADLR has a gap around 15 from October that may prove to be a bounce area. Adolor (ADLR) -24% Small-cap biotech company says that Entereg, its treatment for post-operative bowel obstruction, failed to show a statistically significant benefit at either dose tested; Adolor still plans to submit a new drug application to the FDA anyway as some patients showed benefits